4 studies found for:    alzheimer | elan
Show Display Options
Rank Status Study
1 Recruiting Efficacy and Safety Study of ELND005 as a Treatment for Agitation and Aggression in Alzheimer's Disease
Condition: Alzheimer's Disease
Interventions: Drug: ELND005;   Drug: Placebo
2 Enrolling by invitation A 36-Week Safety Extension Study of ELND005 as a Treatment for Agitation and Aggression in Alzheimer's Disease
Condition: Alzheimer's Disease
Interventions: Drug: Group 1 ELND005;   Drug: Group 2 ELND005
3 Completed
Has Results
ELND005 in Patients With Mild to Moderate Alzheimer's Disease
Condition: Alzheimer Disease
Interventions: Drug: Placebo Control;   Drug: ELND005
4 Completed ELND005 Long-Term Follow-up Study in Subjects With Alzheimer's Disease
Condition: Alzheimer's Disease
Intervention: Drug: ELND005 (scyllo-inositol)

Indicates status has not been verified in more than two years